|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||55.35 - 56.74|
|52 Week Range||33.04 - 69.72|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||71.64|
Tabula Rasa Healthcare (TRHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MOORESTOWN, N.J., July 22, 2020 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its second quarter 2020 operating results on Wednesday, August 5, 2020 at 8 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams. The Company’s financial results for the second quarter ended June 30, 2020, will be released after the close of the market on Tuesday, August 4, 2020. For a live audio webcast of the call, please visit the investor relations section of TRHC’s website (ir.trhc.com). To listen to the conference call, please dial 844-413-0947 or 216-562-0423 for international callers and reference passcode 7358617 approximately 15 minutes prior to the call. A replay of the conference call will be available by phone for seven days after the call, please dial 855-859-2056 or 404-537-3406 for international callers and reference passcode 7358617. Additionally, an audio file of the call also will be archived at ir.trhc.com and available for replay approximately two hours after the live event for a period of 90 days.About Tabula Rasa HealthCare TRHC (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. TRHC provides solutions for a range of payers, providers and other healthcare organizations. For more information, visit TRHC.com.Media Contact Amanda Bednar firstname.lastname@example.org T: (856) 912-5714 Dianne Semingson email@example.com T: (215) 870-0829 Investors Frank Sparacino firstname.lastname@example.org T: (312) 451-2157
CERN vs. TRHC: Which Stock Is the Better Value Option?